However, some studies recognized miR-182-5p as an inhibitor of the process of proliferation; indeed, miR-182-5p downregulates the mRNA products for proteins promoting the cancer development, including CTTN, RGS17, and CREB1 in ovarian papillary carcinoma, gastric adenocarcinoma, and in lung cancer [5,45,46]. The gene discussed is CREB1; the disease is cancer.